Back to ironsteedlabs.com Arcadia Labs LLC d/b/a Iron Steed Labs
Legal & Regulatory Affairs
Iron Steed Labs Arcadia Labs LLC

Compliance Policy

Iron Steed Labs distributes synthetic peptide compounds as chemical reference materials for in-vitro laboratory research. This page documents how we structure our operations to remain within the regulatory framework applicable to chemical reference material distributors in the United States.

Last Updated: April 17, 2026  ·  Arcadia Labs LLC d/b/a Iron Steed Labs

01

What Iron Steed Labs Is — and Is Not

We are a chemical reference material distributor.

Iron Steed Labs (a trade name of Arcadia Labs LLC) supplies synthetic peptide compounds as analytical reference standards and chemical reagents for in-vitro laboratory applications. We are not a pharmacy, compounding facility, drug manufacturer, dietary supplement company, or food producer.

Note on corporate structure: Arcadia Labs LLC operates two distinct business lines. The Arcadia Labs brand works with licensed 503A/503B compounding pharmacies to provide white-labeled solutions to licensed clinicians for patient use. Iron Steed Labs independently distributes Research Use Only (RUO) chemical reference materials to a limited, access-controlled audience of qualified independent researchers. These operations are legally and operationally distinct. This compliance policy governs the Iron Steed Labs RUO distribution business only.

We are not:

A compounding pharmacy under 503A or 503B of the FD&C Act
A drug manufacturer subject to cGMP requirements
A dietary supplement manufacturer under DSHEA
A food producer subject to FSMA
A medical device manufacturer
A DEA registrant — our products are not controlled substances
Our products are not drugs as defined by section 201(g)(1) of the FD&C Act, 21 U.S.C. § 321(g)(1). They are not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. They are not intended to affect the structure or any function of the body. They are chemical reference materials supplied as lyophilized powder for in-vitro laboratory analysis.
02

Intended Use Under 21 CFR 201.128

Under FDA regulations, a product's classification as a "drug" depends on its intended use as defined in 21 CFR 201.128. Intended use is established by objective evidence — including labeling, advertising, oral or written statements, and the totality of circumstances surrounding distribution.

Iron Steed Labs has structured every aspect of its operations to ensure that no objective evidence establishes drug intended use:

1 — Labeling

Every product — on the physical vial and the website — is labeled: "For In-Vitro Laboratory Research Use Only. Not for Human or Animal Consumption. Not Intended to Diagnose, Treat, Cure, or Prevent Any Disease." This language appears prominently and is not buried in fine print or footnotes.

2 — Product Descriptions

Product pages describe chemical properties only: compound name, molecular formula, molecular weight, CAS registry number, amino acid sequence, purity percentage, and testing methodology. Biological activity, receptor binding, mechanism of action, therapeutic effects, and clinical applications are not described on any product page.

3 — No Dosing Information

We provide no dosage recommendations, titration schedules, administration protocols, cycling instructions, or any guidance suggesting use in humans or animals. We do not publish usage guides, protocol documents, or any material describing how to use our products outside of in-vitro laboratory analysis.

4 — No Benefits or Effects Claims

We make no claims — explicit or implied — that any product produces any effect in a human or animal body. We do not use outcome-oriented language such as "weight loss," "muscle recovery," "anti-aging," "fat burning," "cognitive enhancement," "appetite suppression," or "improved glycemic control" anywhere on our website, labeling, or marketing materials.

5 — No Community Forums or Use-Oriented Content

We do not operate, sponsor, link to, or endorse community forums, Discord servers, Telegram groups, Skool communities, or other platforms where our products could be discussed in a use-oriented context. We do not publish or solicit user testimonials describing effects, outcomes, or personal experiences with any product.

6 — No Research Citations on Product Pages

Product pages do not cite, reference, link to, or discuss published research studies, clinical trials, PubMed articles, or preclinical findings. Products are described by chemical identity and analytical specifications only.

03

Product Labeling Standards

Physical Vial Label

Catalog / Product Page

04

Product Catalog Content Policy

The following content standards apply to all product descriptions, catalog entries, and any public or member-facing written material associated with Iron Steed Labs products:

Prohibited Language

Required Content

No Condition-Based Categorization

Products are not organized, categorized, or positioned by disease condition, health outcome, body system, or therapeutic area. Categories are based on compound class or chemical family only (e.g., GLP-1 analogs, melanocortin peptides, growth hormone secretagogues — referring to chemical classification, not therapeutic application).

05

Reconstitution Supply Policy

Iron Steed Labs offers optional ancillary research supply bundles that may include bacteriostatic water, transfer syringes, insulin syringes, and alcohol prep swabs. This section documents our policy rationale and the constraints under which these supplies are offered.

Policy Rationale

Lyophilized peptide compounds require reconstitution with a sterile solvent prior to use in in-vitro laboratory applications. Bacteriostatic water and sterile syringes are standard laboratory consumables used in any setting that works with lyophilized materials — including cell culture labs, biochemistry research, and analytical reference standard preparation. Their inclusion in our catalog reflects the practical needs of qualified independent researchers conducting legitimate in-vitro work.

Constraints and Controls

Operational boundary: Iron Steed Labs does not publish reconstitution guides, injection preparation protocols, dosing schedules, or any instructional content describing how to administer compounds to humans or animals. The presence of ancillary supplies in our catalog is not evidence of drug intended use under 21 CFR 201.128.
06

Buyer Certification & Anti-Diversion

Access Controls

Product purchasing is restricted to a limited, access-controlled audience. New customers must apply through our access request process and are reviewed before being granted purchasing access. Iron Steed Labs does not operate an open public storefront. This screening step is part of our anti-diversion framework.

Purchase Certification

Every buyer is required to certify at the point of purchase — via an explicit, required checkbox confirmation — that they:

These certifications are recorded with each transaction at the time of purchase and are retained as part of our compliance documentation.

Order Screening

Iron Steed Labs reviews orders for patterns or signals that may indicate non-research use. We reserve the right to decline, cancel, or refund any order at our sole discretion. Factors considered include purchasing patterns, order frequency, communications content, and publicly available information about the purchaser.

Account Termination

Any indication — through any channel, including website chat, Instagram DM, email, or order notes — of intent to use our products for human or animal administration results in:

Labeling Integrity

Removal or alteration of "Research Use Only" or "Not for Human or Animal Consumption" designations from any Iron Steed Labs product constitutes a material breach of our Terms of Service and may be reported to regulatory authorities.

07

Analytical Quality Program

Independent Third-Party Testing

Every batch of Iron Steed Labs products is analyzed by an independent third-party laboratory. We do not self-certify product identity or purity.

HPLC Purity Verification

Reversed-phase HPLC is used to verify compound purity. Full chromatogram data is included on every Certificate of Analysis.

Mass Spectrometry Identity Confirmation

ESI-MS (electrospray ionization mass spectrometry) confirms molecular identity by comparing observed and theoretical molecular weight values.

Batch Traceability

Unique lot numbers are assigned to each production batch and appear on vial labels, Certificates of Analysis, and internal records. COAs are available to authorized members upon request.

08

Website Content Policy

No Therapeutic Language

We do not use verbs or phrases implying therapeutic action in connection with any product, including: "treats," "heals," "cures," "prevents," "improves," "enhances," "boosts," "reduces," "stimulates," "inhibits," "activates," "modulates," or "regulates."

No Receptor or Pathway Descriptions

Product pages do not describe receptor binding, signaling pathways, biological mechanisms, or structure-activity relationships. Products are identified by chemical name, CAS number, sequence, formula, molecular weight, and analytical purity only.

No Condition-Based Marketing

We do not organize, categorize, or position products by disease condition, health outcome, or body system effect in any publicly accessible or member-facing marketing material.

AI Chatbot and Instagram Bot Constraints

Our AI-powered inquiry chatbot and Instagram DM bot are trained to provide general informational responses about our catalog and ordering process only. These systems are explicitly constrained from:

09

Regulatory Awareness

FDA Enforcement Landscape

Iron Steed Labs monitors FDA enforcement actions against chemical reference material distributors. We are aware that the FDA has taken action against vendors who — despite "research use only" labeling — established drug intended use through:

Iron Steed Labs does not engage in any of these practices.

Compounding Pharmacy Distinctions

FDA restrictions on certain bulk drug substances under 503A/503B apply to compounding pharmacies preparing patient-specific formulations. Iron Steed Labs is not a compounding pharmacy. We distribute chemical reference materials in their original lyophilized form and do not compound, reconstitute, or prepare patient-specific formulations under the Iron Steed Labs brand.

The Arcadia Labs compounding pharmacy partnership business operates under an entirely separate regulatory framework, with its own licensing, clinical relationships, and compliance structure that is distinct from Iron Steed Labs' RUO distribution activity.

ITC Proceedings

Iron Steed Labs monitors International Trade Commission (ITC) proceedings and reviews applicable exclusion orders. We adjust our product catalog as necessary to comply with any active or forthcoming ITC exclusion orders that may affect our compound offerings.

State Law Compliance

The legality of purchasing, possessing, and using RUO research compounds varies by jurisdiction. It is the responsibility of each buyer to verify compliance with applicable local, state, and federal law before placing an order. Iron Steed Labs reserves the right to restrict shipping to any jurisdiction at its sole discretion.

10

Regulatory Cooperation

Iron Steed Labs will cooperate fully with any legitimate inquiry from the FDA, DEA, FTC, DOJ, state attorney general, or other duly authorized regulatory or law enforcement authority.

We maintain the following records as part of our compliance infrastructure:

11

Reporting Concerns

If you have observed or have reason to believe that Iron Steed Labs products are being misused, diverted, or otherwise used outside of authorized research contexts, please report it. All reports are treated confidentially and reviewed promptly.

Compliance & Legal Contacts Suspected misuse or diversion: compliance@ironsteedlabs.com
Compliance policy questions: legal@ironsteedlabs.com
Privacy matters: privacy@ironsteedlabs.com

Arcadia Labs LLC d/b/a Iron Steed Labs takes compliance seriously as a core operational obligation — not merely a legal formality. We are committed to operating responsibly within the regulatory framework governing chemical reference material distribution in the United States.